GAIL WALDROP: Open Payments
NPI 1154349710 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 33 payments from 16 companies in 2025. Trend: 2023 $803 · 2024 $1,041 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $158 |
| Edwards Lifesciences Corporation | 2 | $61 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, PREVNAR 20, JARDIANCE, GVOKE HYPOPEN, SAPIEN 3 Ultra RESILIA, UBRELVY, GEMTESA, XIFAXAN.
Industry payments across SC — which companies pay providers there.
